Meissa Vaccines Patents – Insights & Stats (Updated 2023)

Meissa Vaccines has a total of 12 patents globally, out of which no patents have been granted. Of these 12 patents, more than 91% patents are active. Parallelly, United States of America seems to be the main focused R&D centre and also is the origin country of Meissa Vaccines.

Meissa Vaccines was founded in the year 2014. The Company operates as a pharmaceutical development company. The Company focuses on the in-licensing and advancement of vaccines for respiratory syncytial virus and rhinovirus. Company offers vaccines that reduces the burden of acute lower respiratory tract disease, cold, and asthma.

Do read about some of the most popular patents of Meissa Vaccines which have been covered by us in this article and also you can find Meissa Vaccines patents information, the worldwide patent filing activity and its patent filing trend over the years, and many other stats over Meissa Vaccines patent portfolio.

How many patents does Meissa Vaccines have?

Meissa Vaccines has a total of 12 patents globally. These patents belong to 2 unique patent families. Out of 12 patents, 11 patents are active.

How Many Patents did Meissa Vaccines File Every Year?

Meissa Vaccines Patent Filing Trend

Are you wondering why there is a drop in patent filing for the last two years? It is because a patent application can take up to 18 months to get published. Certainly, it doesn’t suggest a decrease in the patent filing.

Year of Patents Filing or GrantMeissa Vaccines Applications FiledMeissa Vaccines Patents Granted
20231
20222
20219

How many Meissa Vaccines patents are Alive/Dead?

Meissa Vaccines Patent Portfolio

 How Many Patents did Meissa Vaccines File in Different Countries?

Meissa Vaccines Worldwide Patent Filing

Countries in which Meissa Vaccines Filed Patents

CountryPatents
Taiwan1
Japan1
Argentina1
Brazil1
Mexico1
Canada1
Australia1
United States Of America1
Europe1
Hong Kong (S.A.R.)1

Where are Research Centres of Meissa Vaccines Patents Located?

The Research Centre for all the Meissa Vaccines patents is the United States of America.

List of Meissa Vaccines Patents

Meissa Vaccines PatentsTitle
US20230248815A1Chimeric Rsv And Coronavirus Proteins, Immunogenic Compositions, And Methods Of Use
EP4168045A1Chimeric Rsv And Coronavirus Proteins, Immunogenic Compositions, And Methods Of Use
HK40091689AChimeric Rsv And Coronavirus Proteins, Immunogenic Compositions, And Methods Of Use
WO2023092100A3Methods Of Administering Chimeric Vaccines
JP2023530445AChimeric Rsv And Coronavirus Proteins, Immunogenic Compositions And Methods Of Use
MX2022016502ARsv And Coronavirus Chimeric Proteins, Immunogenic Compositions And Methods Of Use
BR112022025647A2Rsv And Coronavirus Chimeric Proteins, Immunogenic Compositions And Methods Of Use
AU2021292397A1Chimeric Rsv And Coronavirus Proteins, Immunogenic Compositions, And Methods Of Use
AR122651A1Rsv And Coronavirus Chimeric Proteins, Immunogenic Compositions, And Methods Of Use
TW202208399AChimeric Rsv And Coronavirus Proteins, Immunogenic Compositions, And Methods Of Use
CA3187161A1Chimeric Rsv And Coronavirus Proteins, Immunogenic Compositions, And Methods Of Use
WO2021257841A9Chimeric Rsv And Coronavirus Proteins, Immunogenic Compositions, And Methods Of Use

What are Meissa Vaccines key innovation segments?

What Technologies are Covered by Meissa Vaccines?

The chart below distributes patents filed by Meissa Vaccines in different countries on the basis of the technology protected in patents. It also represents the markets where Meissa Vaccines thinks it’s important to protect particular technology inventions.

R&D Focus: How has Meissa Vaccines search focus changed over the years?

EXCLUSIVE INSIGHTS COMING SOON!

Interested in knowing about the areas of innovation that are being protected by Meissa Vaccines?

Related Articles

Monetago Patents – Insights and Stats (Updated 2024)

Monetago has a total of 10 patents globally, out of which none have been granted. Of these 10 patents, all the patents are inactive. The United States of America is where Monetago has filed all their patents. Parallelly, United States of America seems to be the main focused R&D centre

Read More »

Leave a Comment

Fill the form to get the details:

Fill the form to get the details:

Our comprehensive report provides an in-depth look into the patent portfolio. The report includes a breakdown of the patent portfolio across various technologies, listing the patent along with brief summaries of each patent's technology.